SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LCI - Lannett Company, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: richardred who wrote (26)1/21/2007 2:43:18 PM
From: richardred  Respond to of 81
 
Per 2006 Annual Report

Product overlap competition-
DIGOXIN Tablets-mfg by JSP-indication-congestive heart failure-Caraco

DOXYCYCLINE Tablets-indication-antibiotic-Ranbaxy

Stages of FDA review-ANDA-products-7 supplements-3

Jan 19 (Reuters) - Caraco Pharmaceutical Laboratories Ltd. (CPD.A: Quote, Profile , Research) said an appeals court upheld the ruling of a federal court that its generic version of painkiller Ultracet does not infringe upon Ortho-McNeil Pharmaceutical Inc.'s patent.

Caraco's Tramadol with Acetaminophen is the generic equivalent of Ortho-McNeil's Ultracet, the company said in a statement.

Ortho-McNeil is a unit of Johnson & Johnson Inc. (JNJ.N: Quote, Profile , Research). (Reporting by Jennifer Robin Raj in Bangalore)

Reuters Pictures
Photo

Editors Choice: Best pictures
from the last 24 hours.
View Slideshow

© Reuters 2007. All Rights Reserved.
yahoo.reuters.com